SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009693
Filing Date
2022-05-12
Accepted
2022-05-12 16:25:56
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-20220331.htm   iXBRL 10-Q 2197162
2 EX-10.1 nktx-ex10_1.htm EX-10.1 39481
3 EX-31.1 nktx-ex31_1.htm EX-31.1 21210
4 EX-31.2 nktx-ex31_2.htm EX-31.2 20600
5 EX-32 nktx-ex32.htm EX-32 20032
  Complete submission text file 0000950170-22-009693.txt   7378417

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20220331_lab.xml EX-101.LAB 379599
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20220331_pre.xml EX-101.PRE 273958
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20220331.xsd EX-101.SCH 38688
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktx-20220331_def.xml EX-101.DEF 148461
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktx-20220331_cal.xml EX-101.CAL 45890
53 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20220331_htm.xml XML 1324602
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 22918230
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences